This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mirjana Kessler: Innovator in Ovarian Cancer Research
Introduction
Mirjana Kessler is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of cancer research, particularly focusing on ovarian cancer. Her innovative work has led to the development of a unique method for producing organoid cultures of ovarian cancer cells.
Latest Patents
Kessler holds a patent for her invention titled "Ovarian cancer organoid culture." This patent describes a method for producing a culture, specifically an organoid culture of ovarian cancer or cancer precursor cells, particularly high-grade serous ovarian carcinoma cells. The method allows for the generation of an organoid culture and a biobank comprising various organoid cultures of ovarian cancer or cancer precursor cells. Additionally, it provides a culture medium suitable for the long-term culture of these cells. The organoid culture and biobank have potential medical applications in diagnostics, therapy, and drug screening.
Career Highlights
Kessler is affiliated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., where she conducts her research. Her work has been instrumental in advancing the understanding of ovarian cancer and developing new therapeutic approaches.
Collaborations
One of her notable collaborators is Thomas F. Meyer, with whom she has worked on various research projects related to cancer.
Conclusion
Mirjana Kessler's innovative contributions to ovarian cancer research through her patented organoid culture method highlight her role as a leading inventor in the field. Her work not only enhances scientific understanding but also paves the way for future medical advancements.